Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure

被引：91

作者：

Di Campli, C. ^{[1
]}

Zocco, M. A. ^{[2
]}

Saulnier, N. ^{[2
]}

Grieco, A. ^{[2
]}

Rapaccini, G. ^{[2
]}

Addolorato, G. ^{[2
]}

Rumi, C. ^{[3
]}

Santoliquido, A. ^{[2
]}

Leone, G. ^{[3
]}

Gasbarrini, G. ^{[2
]}

Gasbarrini, A. ^{[2
]}

机构：

[1] IDI IRCCS, Vasc Pathol Lab, I-00167 Rome, Italy

[2] Univ Cattolica Sacro Cuore, Dept Internal Med, Rome, Italy

[3] Univ Cattolica Sacro Cuore, Dept Haematol, Rome, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2007年 / 39卷 / 12期

关键词：

bone marrow stem cells; G-CSF; liver regeneration;

D O I：

10.1016/j.dld.2007.08.006

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background/aim. We aimed to evaluate safety and efficacy of granulocyte-colony stimulating factor treatment in patients with acute on chronic liver failure and the effect of granulocyte-colony stimulating factor on the expression level of CXCR4, vascular endothelial growth factor receptor and very late activation antigen 4. Methods. Twenty-four patients with acute on chronic liver failure were randomised to receive standard therapy, standard therapy + granulocyte-colony stimulating factor (5 mu g/kg/day for 6 days) and standard therapy + granulocyte-colony stimulating factor (15 mu g/kg/day s.c. for 6 days). Data on CD34+cell mobilisation were compared to age-matched peripheral blood haematopoietic stem cell donors treated with granulocyte-colony stimulating factor. On day third of treatment, the expression level of CXCR4, vascular endothelial growth factor receptor and very late activation antigen 4 was analysed in mobilised CD34+ cells. Results. CD34 cell count increased after the second day of granulocyte-colony stimulating factor injection in both treatment groups compared to the linear increase observed in control. After the fifth day the increase was significantly higher in healthy donors versus patients with acute on chronic liver failure. A decrease in the expression of CXCR4, very late activation antigen 4 and vascular endothelial growth factor receptor compared to premobilisation values was observed. No major side effects were observed. Conclusions. Granulocyte-colony stimulating factor treatment is able to induce CD34 mobilisation in patients with acute on chronic liver failure. The expression pattern of CXCR4, very late activation antigen 4 and vascular endothelial growth factor receptor suggests that these molecules are involved in the granulocyte-colony stimulating factor-induced stem cell mobilisation. (C) 2007 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

引用

页码：1071 / 1076

页数：6

共 35 条

[1]

Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1002/hep.510230122

[2]

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells [J].